Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37567068)

  • 1. Active bone marrow segmentation based on computed tomography imaging in anal cancer patients: A machine-learning-based proof of concept.
    Fiandra C; Rosati S; Arcadipane F; Dinapoli N; Fato M; Franco P; Gallio E; Scaffidi Gennarino D; Silvetti P; Zara S; Ricardi U; Balestra G
    Phys Med; 2023 Sep; 113():102657. PubMed ID: 37567068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating
    Franco P; Fiandra C; Arcadipane F; Trino E; Giglioli FR; Ragona R; Ricardi U
    BMC Cancer; 2017 Nov; 17(1):710. PubMed ID: 29096619
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Li H; Xu C; Xin B; Zheng C; Zhao Y; Hao K; Wang Q; Wahl RL; Wang X; Zhou Y
    Theranostics; 2019; 9(16):4730-4739. PubMed ID: 31367253
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow segmentation and radiomics analysis of [
    Milara E; Gómez-Grande A; Tomás-Soler S; Seiffert AP; Alonso R; Gómez EJ; Martínez-López J; Sánchez-González P
    Comput Methods Programs Biomed; 2022 Oct; 225():107083. PubMed ID: 36044803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-automated histogram analysis of normal bone marrow using
    Satoh Y; Funayama S; Onishi H; Kirito K
    BMC Med Imaging; 2022 Feb; 22(1):31. PubMed ID: 35197004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of bone marrow invasion on the machine learning of 18 F-FDG PET texture analysis in lower gingival squamous cell carcinoma.
    Fukushima Y; Suzuki K; Kim M; Gu W; Yokoo S; Tsushima Y
    Nucl Med Commun; 2024 May; 45(5):406-411. PubMed ID: 38372047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation.
    Rose BS; Jee KW; Niemierko A; Murphy JE; Blaszkowsky LS; Allen JN; Lee LK; Wang Y; Drapek LC; Hong TS; Wo JY
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):747-54. PubMed ID: 26972647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Response of Pelvic Bone Marrow Fluorodeoxyglucose Uptake in Patients Receiving Concurrent Chemoradiotherapy.
    Robinson M; Muirhead R; McGowan DR; Chu KY; Jacobs C; Hawkins MA
    Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):e622-e627. PubMed ID: 37339923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics analysis of bone marrow biopsy locations in [
    Milara E; Alonso R; Masseing L; Seiffert AP; Gómez-Grande A; Gómez EJ; Martínez-López J; Sánchez-González P
    Phys Eng Sci Med; 2023 Jun; 46(2):903-913. PubMed ID: 37155114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial.
    Yusufaly T; Miller A; Medina-Palomo A; Williamson CW; Nguyen H; Lowenstein J; Leath CA; Xiao Y; Moore KL; Moxley KM; Chevere-Mourino CM; Eng TY; Zaid T; Mell LK
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1240-1247. PubMed ID: 32629079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Marrow and Tumor Radiomics at
    Mattonen SA; Davidzon GA; Benson J; Leung ANC; Vasanawala M; Horng G; Shrager JB; Napel S; Nair VS
    Radiology; 2019 Nov; 293(2):451-459. PubMed ID: 31526257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined clinical and specific positron emission tomography/computed tomography-based radiomic features and machine-learning model in prediction of thymoma risk groups.
    Ozkan E; Orhan K; Soydal C; Kahya Y; Seckin Tunc S; Celik O; Dizbay Sak S; Kayi Cangir A
    Nucl Med Commun; 2022 May; 43(5):529-539. PubMed ID: 35234213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron Emission Tomography-based Analysis Can Accurately Predict Bone Marrow Involvement With Mantle Cell Lymphoma.
    Morgan R; Perry M; Kwak J; Jensen A; Kamdar M
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):731-736. PubMed ID: 30075973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma.
    Sager S; Ergül N; Ciftci H; Cetin G; Güner SI; Cermik TF
    Skeletal Radiol; 2011 Jul; 40(7):843-7. PubMed ID: 21229354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics based on
    Ou X; Zhang J; Wang J; Pang F; Wang Y; Wei X; Ma X
    Cancer Med; 2020 Jan; 9(2):496-506. PubMed ID: 31769230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.